RhoA as a Key Regulator of Innate and Adaptive Immunity

RhoA is a ubiquitously expressed cytoplasmic protein that belongs to the family of small GTPases. RhoA acts as a molecular switch that is activated in response to binding of chemokines, cytokines, and growth factors, and via mDia and the ROCK signaling cascade regulates the activation of cytoskeleta...

Full description

Bibliographic Details
Main Authors: Matthias Bros, Katharina Haas, Lorna Moll, Stephan Grabbe
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/7/733
_version_ 1797709859823550464
author Matthias Bros
Katharina Haas
Lorna Moll
Stephan Grabbe
author_facet Matthias Bros
Katharina Haas
Lorna Moll
Stephan Grabbe
author_sort Matthias Bros
collection DOAJ
description RhoA is a ubiquitously expressed cytoplasmic protein that belongs to the family of small GTPases. RhoA acts as a molecular switch that is activated in response to binding of chemokines, cytokines, and growth factors, and via mDia and the ROCK signaling cascade regulates the activation of cytoskeletal proteins, and other factors. This review aims to summarize our current knowledge on the role of RhoA as a general key regulator of immune cell differentiation and function. The contribution of RhoA for the primary functions of innate immune cell types, namely neutrophils, macrophages, and conventional dendritic cells (DC) to (i) get activated by pathogen-derived and endogenous danger signals, (ii) migrate to sites of infection and inflammation, and (iii) internalize pathogens has been fairly established. In activated DC, which constitute the most potent antigen-presenting cells of the immune system, RhoA is also important for the presentation of pathogen-derived antigen and the formation of an immunological synapse between DC and antigen-specific T cells as a prerequisite to induce adaptive T cell responses. In T cells and B cells as the effector cells of the adaptive immune system Rho signaling is pivotal for activation and migration. More recently, mutations of Rho and Rho-modulating factors have been identified to predispose for autoimmune diseases and as causative for hematopoietic malignancies.
first_indexed 2024-03-12T06:43:56Z
format Article
id doaj.art-20a6146834bb4eefada480c8296a5f5e
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T06:43:56Z
publishDate 2019-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-20a6146834bb4eefada480c8296a5f5e2023-09-03T00:45:45ZengMDPI AGCells2073-44092019-07-018773310.3390/cells8070733cells8070733RhoA as a Key Regulator of Innate and Adaptive ImmunityMatthias Bros0Katharina Haas1Lorna Moll2Stephan Grabbe3University Medical Center Mainz, Department of Dermatology, Langenbeckstraße 1, 55131 Mainz, GermanyUniversity Medical Center Mainz, Department of Dermatology, Langenbeckstraße 1, 55131 Mainz, GermanyUniversity Medical Center Mainz, Department of Dermatology, Langenbeckstraße 1, 55131 Mainz, GermanyUniversity Medical Center Mainz, Department of Dermatology, Langenbeckstraße 1, 55131 Mainz, GermanyRhoA is a ubiquitously expressed cytoplasmic protein that belongs to the family of small GTPases. RhoA acts as a molecular switch that is activated in response to binding of chemokines, cytokines, and growth factors, and via mDia and the ROCK signaling cascade regulates the activation of cytoskeletal proteins, and other factors. This review aims to summarize our current knowledge on the role of RhoA as a general key regulator of immune cell differentiation and function. The contribution of RhoA for the primary functions of innate immune cell types, namely neutrophils, macrophages, and conventional dendritic cells (DC) to (i) get activated by pathogen-derived and endogenous danger signals, (ii) migrate to sites of infection and inflammation, and (iii) internalize pathogens has been fairly established. In activated DC, which constitute the most potent antigen-presenting cells of the immune system, RhoA is also important for the presentation of pathogen-derived antigen and the formation of an immunological synapse between DC and antigen-specific T cells as a prerequisite to induce adaptive T cell responses. In T cells and B cells as the effector cells of the adaptive immune system Rho signaling is pivotal for activation and migration. More recently, mutations of Rho and Rho-modulating factors have been identified to predispose for autoimmune diseases and as causative for hematopoietic malignancies.https://www.mdpi.com/2073-4409/8/7/733small GTPasesRhoA signalingimmune cellsautoimmune diseasesinfectioninflammasome
spellingShingle Matthias Bros
Katharina Haas
Lorna Moll
Stephan Grabbe
RhoA as a Key Regulator of Innate and Adaptive Immunity
Cells
small GTPases
RhoA signaling
immune cells
autoimmune diseases
infection
inflammasome
title RhoA as a Key Regulator of Innate and Adaptive Immunity
title_full RhoA as a Key Regulator of Innate and Adaptive Immunity
title_fullStr RhoA as a Key Regulator of Innate and Adaptive Immunity
title_full_unstemmed RhoA as a Key Regulator of Innate and Adaptive Immunity
title_short RhoA as a Key Regulator of Innate and Adaptive Immunity
title_sort rhoa as a key regulator of innate and adaptive immunity
topic small GTPases
RhoA signaling
immune cells
autoimmune diseases
infection
inflammasome
url https://www.mdpi.com/2073-4409/8/7/733
work_keys_str_mv AT matthiasbros rhoaasakeyregulatorofinnateandadaptiveimmunity
AT katharinahaas rhoaasakeyregulatorofinnateandadaptiveimmunity
AT lornamoll rhoaasakeyregulatorofinnateandadaptiveimmunity
AT stephangrabbe rhoaasakeyregulatorofinnateandadaptiveimmunity